PRIONRX SCIENCE Trademark

Trademark Overview

On Tuesday, February 23, 2021, a trademark application was filed for PRIONRX SCIENCE with the United States Patent and Trademark Office. The USPTO has given the PRIONRX SCIENCE trademark a serial number of 90541303. The federal status of this trademark filing is REGISTERED as of Tuesday, September 6, 2022. This trademark is owned by Amprion, Inc.. The PRIONRX SCIENCE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical diagnosis of neurodegenerative diseases
prionrx science

General Information

Serial Number90541303
Word MarkPRIONRX SCIENCE
Filing DateTuesday, February 23, 2021
Status700 - REGISTERED
Status DateTuesday, September 6, 2022
Registration Number6840498
Registration DateTuesday, September 6, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 16, 2021

Trademark Statements

Goods and ServicesMedical diagnosis of neurodegenerative diseases
Disclaimer with Predetermined Text"SCIENCE"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 24, 2021
Primary Code044
First Use Anywhere DateMonday, June 20, 2022
First Use In Commerce DateMonday, June 20, 2022

Trademark Owner History

Party NameAmprion, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105
Party NameAmprion, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105
Party NameAmprion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105

Trademark Events

Event DateEvent Description
Tuesday, September 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 6, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, August 4, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 3, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, July 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 29, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 13, 2022USE AMENDMENT FILED
Friday, July 29, 2022SOU EXTENSION 1 GRANTED
Monday, July 11, 2022SOU EXTENSION 1 FILED
Thursday, July 28, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 13, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, July 13, 2022NOTICE OF REVIVAL - E-MAILED
Wednesday, July 13, 2022EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, July 13, 2022PETITION TO REVIVE-GRANTED
Wednesday, July 13, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, January 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 6, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 20, 2021NON-FINAL ACTION E-MAILED
Monday, September 20, 2021NON-FINAL ACTION WRITTEN
Friday, September 17, 2021ASSIGNED TO EXAMINER
Monday, May 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 26, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords

science prionrx diseases neurodegenerative diagnosis medical